HeartBeam Ranks Second Worldwide in 12-Lead ECG Innovation According to PatentVest Report

HeartBeam, a medical-technology company developing advanced electrocardiogram solutions, was recently featured in an article discussing its recognition as a Global IP and Technology Leader in Portable Cardiac Diagnostics by PatentVest's "Total Cardiac Intelligence" report. The company ranked second worldwide in 12-lead ECG innovation among 243 firms analyzed, trailing only GE Healthcare. This recognition highlights HeartBeam's growing influence in the next generation of cardiac monitoring technology and underscores the rapid maturation of the company's proprietary synthesis-ECG system.

The company's technology captures the heart's electrical signals in three noncoplanar dimensions and synthesizes them into a 12-lead ECG. This unique approach allows physicians to obtain cardiologist-level ECG data from compact devices that can be used by patients or clinicians far from traditional hospital settings. In doing so, HeartBeam is addressing one of modern medicine's most persistent challenges: delivering high-quality cardiac monitoring for arrhythmia assessment wherever patients are. The company is cleared for arrhythmia today, with ischemia as a future goal.

HeartBeam is creating the first-ever cable-free 12-lead ECG capable of capturing the heart's electrical signals from three dimensions. This platform technology is designed to be used in portable devices that can be used wherever the patient is to deliver actionable heart intelligence. Physicians will be able to identify cardiac health trends and acute conditions and direct patients to the appropriate care—all outside of a medical facility, thus redefining the future of cardiac health management. The company holds 13 U.S. and 4 international-issued patents related to technology enablement.

The implications of this recognition are significant for the future of cardiac care. As healthcare continues to shift toward remote monitoring and telemedicine, technologies like HeartBeam's could enable earlier detection of cardiac issues and improve outcomes for patients who cannot easily access traditional medical facilities. The ranking suggests that HeartBeam's approach to portable ECG technology is gaining traction in the competitive medical device landscape. For more information about the company, visit https://www.HeartBeam.com. Additional news and updates relating to BEAT are available in the company's newsroom at https://ibn.fm/BEAT.